G-actin sequestration

G-actin sequestration refers to the reversible binding of monomeric globular actin (G-actin) by intracellular sequestering proteins, most prominently members of the thymosin beta family. This binding keeps G-actin in a soluble, polymerization-competent but non-filamentous state, creating a dynamic buffer that controls the free G-actin concentration available to drive barbed-end polymerization of F-actin (filamentous actin) and thus regulates the rate and directionality of cytoskeletal reorganization.

Why it matters in peptide research

Actin dynamics are fundamental to cell migration, wound healing, immune cell function, and tissue remodeling. During wound repair, keratinocytes, fibroblasts, endothelial cells, and immune cells must rapidly migrate from wound margins into the injury zone — a process requiring precisely coordinated cycles of actin polymerization at the leading edge and depolymerization at the trailing edge. The availability of the G-actin pool is a rate-limiting factor in this migration.

Thymosin beta-4 (Tβ4), the endogenous peptide that sequesters the largest pool of G-actin in mammalian cells (estimated at 400–600 µM in many cell types), normally keeps actin in a sequestered, reserve state. Upon cell activation by chemotactic signals, thymosin beta-4 releases G-actin to profilin and actin nucleators (Arp2/3, formins) that direct filament growth at the membrane. This regulated release is what allows cells to rapidly extend lamellipodia and filopodia toward repair signals.

Exogenous administration of thymosin beta-4 — or its bioavailable synthetic form TB-500 — provides additional sequestered G-actin reserve, increasing the pool available for rapid mobilization upon activation. This enhances the speed and completeness of cell migration into wound beds, accelerates re-epithelialization, and supports endothelial cell recruitment for angiogenesis. The peptide also has direct signaling roles beyond actin sequestration: it modulates inflammatory cytokine expression, promotes cardiomyocyte survival, and upregulates VEGF expression.

Peptides that act on this

• TB-500 (synthetic Thymosin Beta-4 fragment) — the primary actin-sequestering peptide used in research; increases G-actin reserve and cell motility in wound healing, muscle repair, and angiogenesis models; upregulates VEGF as a secondary angiogenic mechanism.
• Thymosin Beta-4 — full-length endogenous 43-amino-acid peptide; TB-500 is a fragment corresponding to the actin-binding region.

Common misconceptions

G-actin sequestration by thymosin beta-4 is sometimes described as "blocking" actin polymerization — a mischaracterization that frames the sequestered pool as inert. In reality, sequestered G-actin is a charged, ready reservoir: the sequestration is dynamically regulated and instantly reversible upon cellular activation, making it a storage mechanism for rapid-response cytoskeletal remodeling rather than a static inhibitory state. TB-500's benefit comes precisely from expanding this readily mobilizable reserve, not from inhibiting filament formation.